PATIENTS WITH RECURRENT HCV INFECTION AND UNDER ANGIOTENSIN RECEPTOR BLOCKERS AFTER LIVER TRANSPLANTATION HAVE SLOWER HISTOLOGICAL PROGRESSION

被引：0
|
作者：
Cholongitas, E. [2 ,3 ]
Quaglia, A. [1 ]
Samonakis, D. [2 ,3 ]
Manousou, P. [2 ,3 ]
Papatheodoridis, G. [2 ,3 ]
Senzolo, M. [2 ,3 ]
Patch, D. [2 ,3 ]
Dhillon, A. [1 ]
Burroughs, A. [2 ,3 ]
机构：
[1] Royal Free Hosp, Dept Histopathol, London NW3 2QG, England
[2] Royal Free Hosp, Dept Surg, London NW3 2QG, England
[3] Royal Free Hosp, Royal Free Sheila Sherlock Liver Ctr, London NW3 2QG, England
来源：
JOURNAL OF HEPATOLOGY | 2009年 / 50卷
关键词：
D O I：
10.1016/S0168-8278(09)60455-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
453
引用
收藏
页码：S171 / S171
页数：1
相关论文
共 50 条
  • [1] Patients with recurrent HCV infection and renal dysfunction after liver transplantation have slower fibrosis progression
    Cholongitas, E.
    Quaglia, A.
    Samonakis, D.
    Papatheodoridis, G. V.
    Senzolo, M.
    Triantos, C.
    Patch, D.
    Dhillon, A. P.
    Burroughs, A. K.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S58 - S59
  • [2] Patients with recurrent HCV infection and renal dysfunction after liver transplantation have slower fibrosis progression.
    Cholongitas, E
    Quaglia, A
    Samonakis, D
    Papatheodoridis, GV
    Patch, D
    Dhillon, AP
    Burroughs, AK
    LIVER TRANSPLANTATION, 2006, 12 (05) : C60 - C60
  • [3] TREATMENT FOR RECURRENT HCV INFECTION AFTER LIVER TRANSPLANTATION
    Guedes, Cassia
    Pousa, Fernanda
    Roma, Joyce
    Gonzalez, Ana Carolina
    Agolia, Luciana
    Enne, Marcelo
    Martinho, Jose Manoel
    Carius, Luciana
    Balbi, Elizabeth
    Pacheco-Moreira, Lucio
    LIVER TRANSPLANTATION, 2009, 15 (07) : S131 - S131
  • [4] New Insights in Recurrent HCV Infection after Liver Transplantation
    Hsu, Shih-Hsien
    Yeh, Ming-Lun
    Wang, Shen-Nien
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2013,
  • [5] Histopathologic analysis of the progression to cirrhosis in patients with recurrent hepatitis C viral (HCV) infection after liver transplantation.
    Schiano, TD
    Fiel, MI
    Ye, MQ
    Min, AD
    Kim-Schluger, L
    Sheiner, PA
    Sigal, SH
    Thung, SN
    Bodenheimer, HC
    HEPATOLOGY, 1999, 30 (04) : 658A - 658A
  • [6] Recurrent HCV infection reduces the requirement for tacrolimus after liver transplantation
    van den Berg, AP
    Haagsma, EB
    Gouw, ASH
    Slooff, MJH
    Jansen, PLM
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1467 - 1467
  • [7] Comparison of histological progression of recurrent HCV infection in live donor (LDLT) versus cadaveric liver transplantation (CLT) recipients.
    Zaghla, H
    Kanel, GC
    Donovan, JA
    Kahn, JA
    Genyk, Y
    Ramicone, E
    Selby, RR
    Fong, TL
    HEPATOLOGY, 2003, 38 (04) : 652A - 652A
  • [8] Fibrosis progression on protocol liver biopsies in patients with recurrent HCV following liver transplantation
    De Martin, Eleonora
    Boninsegna, Sara
    Senzolo, Marco
    Guido, Maria
    Gambata, Martina
    Germani, Giacomo
    Masier, Annalisa
    Zanus, Giacomo
    Cillo, Umberto
    Burra, Patrizia
    HEPATOLOGY, 2007, 46 (04) : 478A - 478A
  • [9] Angiotensin II antagonists in patients with recurrent hepatitis C virus infection after liver transplantation
    Cholongitas, Evangelos
    Vibhakorn, Shusang
    Lodato, Francesca
    Burroughs, Andrew K.
    LIVER INTERNATIONAL, 2010, 30 (02) : 335 - 335
  • [10] The impact of nonalcoholic fatty liver disease and the metabolic syndrome on progression of fibrosis in patients with recurrent HCV after liver transplantation
    Mindikoglu, A. L.
    Regev, A.
    Casanova-Romero, P. Y.
    Bejarano, P. A.
    Martinez, E. J.
    Tzakis, A. G.
    Schiff, E. R.
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (05) : 1440 - 1444
12345